Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Everolimus for Giant Cell Astrocytomas in Tuberous Sclerosis Complex
NCT00411619Phase 2Completed
- Sponsor
- Cincinnati Children's Hospital Medical Center
- Start
- Jan 2007
- Primary completion
- Jan 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of everolimus in subependymal giant cell astrocytoma (SEGA), sponsored by Cincinnati Children's Hospital Medical Center. Started Jan 2007; status: completed.
02
Drugs
everolimus
03
Conditions
subependymal giant cell astrocytoma (SEGA)
Beyond the preview
Go deeper on NCT00411619.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00411619.